Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006
BioMS Medical licenses these patents on an exclusive worldwide basis from the University of Alberta.
The most recent patent, entitled "Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient," has been granted in the United States and addresses methods of predicting efficacy of certain courses of treatment for MS patients.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly